Quick answer Screen intramuscular biologic administration against severe thrombocytopenia.
Why this is correct The platelet count and petechiae require an individualized administration decision. Route changes and forceful manipulation are not independent nursing substitutions.
Easy analogy or mental picture Use a closed medication-safety loop: identify the immune or cytotoxic exposure, connect the new findings, interrupt further harm, stabilize the client, and verify the response over time.
Memory hook Exposure, immune effect, organ toxicity, infection risk, immediate action, and serial reassessment.
NCLEX decision rule Choose the action that reduces the most immediate medication-related risk while preserving diagnostic evaluation and authorized treatment.
Why the other choices are wrong Options that continue the exposure, treat only one symptom, or delay reassessment leave the toxic or infectious process active.
References
1DailyMed: BEYFORTUS (nirsevimab)RSV lower respiratory tract disease prevention, serious hypersensitivity, and caution with bleeding disorders
Oncology, transplant, and biologic safety reviewVerify the indication, immune status, infection screen, interacting medicines, current organ findings, authorized action, and measurable follow-up.